Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations.

Background: The popularity of quality-adjusted life years (QALYs) has been resistant to concerns about validity and reliability. Utility-theoretic outcome equivalents are widely used in other areas of applied economics. Equivalence values can be derived for time, money, risk, and other metrics. Thes...

Descripción completa

Detalles Bibliográficos
Publicado en:Value in Health Vol. 22; no. 6; pp. 684 - 693
Autores principales: Johnson, F. Reed, Scott, Frank I., Reed, Shelby D., Lewis, James D., Bewtra, Meenakshi
Formato: research Journal Article
Publicado: Elsevier B.V. Jun2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136934953&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 136934953
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10983015
        FSN
      jtl: Value in Health
      issn: 10983015
      maglogo: N
    pubinfo:
      dt: Jun2019
      vid: 22
      iid: 6
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        136934953
        136934953
        NLM31198186
        136934953
        10.1016/j.jval.2019.03.011
        NLM31198186
        136934953
      ppf: 684
      ppct: 9
      formats:
      tig:
        atl: Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations.
      aug:
        au:
          Johnson, F. Reed
          Scott, Frank I.
          Reed, Shelby D.
          Lewis, James D.
          Bewtra, Meenakshi
        affil: Department of Population Health Sciences & Duke Clinical Research Institute, Duke University, Durham, NC, USA
      sug:
        subj:
          Quality-Adjusted Life Years
          Cost Benefit Analysis Standards
          Models, Statistical
          Cost Benefit Analysis Statistics and Numerical Data
          Reproducibility of Results
          Human
          Time Factors
          Cost Benefit Analysis Methods
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Ferrans and Powers Quality of Life Index
          Questionnaires
          Scales
      ab: Background: The popularity of quality-adjusted life years (QALYs) has been resistant to concerns about validity and reliability. Utility-theoretic outcome equivalents are widely used in other areas of applied economics. Equivalence values can be derived for time, money, risk, and other metrics. These equivalence measures preserve all available information about individual preferences and are valid measures of individual welfare changes.Objective: The objective of this study was to derive alternative generalized equivalence measures from first principles and illustrate their application in an empirical comparative-effectiveness example.Methods: We specify a general-equilibrium model incorporating neoclassical utility functions, health production function, severity-duration preferences, and labor-market tradeoff function. The empirical implementation takes advantage of discrete-choice experiment methods that are widely accepted in other areas of applied economics and increasingly in health economics. We illustrate the practical significance of restrictive QALY assumptions using comparative-effectiveness results based on both QALYs and estimates of welfare-theoretic time-equivalent values for anti-tumor necrosis factor and prolonged corticosteroid treatments for Crohn's disease in three distinct preference classes.Results: The QALY difference between the two treatments is 0.2 months, while time-equivalent values range between 0.5 and 1.3 months for aggregate and class-specific differences. Thus, the QALY-based analysis understates welfare-theoretic values by 60%-85%.Conclusion: These results suggest that using disease-specific equivalence values offer a meaningful alternative to QALYs to compare global outcomes across treatments. The equivalence values approach is consistent with principles of welfare economics and offers several features not represented in QALYs, including accounting for preference nonlinearities in disease severity and duration, inclusion of preference-relevant nonclinical healthcare factors, representing preferences of clinically-relevant patient subpopulations, and including utility losses related to risk aversion.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N